ZAI LAB LIMITED Payments of Stock Issuance Costs
ZAI LAB LIMITED (ZLAB) reported Payments of Stock Issuance Costs of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-06
- ZAI LAB LIMITED payments of stock issuance costs for the quarter ending 2026-06-30 was $0.00.
- ZAI LAB LIMITED payments of stock issuance costs for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ZAI LAB LIMITED payments of stock issuance costs for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ZAI LAB LIMITED payments of stock issuance costs for the quarter ending 2025-09-30 was $0.00.
- ZAI LAB LIMITED payments of stock issuance costs for fiscal 2025 was $854.00K, a 33.44% decline from fiscal 2024.
- ZAI LAB LIMITED payments of stock issuance costs for fiscal 2024 was $1.28M.
- ZAI LAB LIMITED payments of stock issuance costs for fiscal 2023 was $0.00.
- ZAI LAB LIMITED payments of stock issuance costs for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $854.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-06 | $854.00K 10-Q · filed 2025-11-06 | $2.14M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $854.00K 10-Q · filed 2026-08-06 | $2.14M derived: sum of 3 quarters · filed 2026-08-06 | $2.14M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $854.00K 10-Q · filed 2026-05-07 | $2.14M derived: sum of 2 quarters · filed 2026-05-07 | $2.14M derived: sum of 3 quarters · filed 2026-05-07 | $2.14M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.28M derived: sum of 2 quarters · filed 2026-02-26 | $1.28M derived: sum of 3 quarters · filed 2026-02-26 | $1.28M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 derived: sum of 2 quarters · filed 2025-02-27 | $0.00 derived: sum of 3 quarters · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $1.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $1.00K derived: sum of 3 quarters · filed 2024-02-27 | $514.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $1.00K derived: sum of 2 quarters · filed 2024-02-27 | $514.00K derived: sum of 3 quarters · filed 2024-02-27 | $864.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $514.00K derived: sum of 2 quarters · filed 2024-02-27 | $864.00K derived: sum of 3 quarters · filed 2024-02-27 | $1.84M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $513.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $863.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.84M 10-Q · filed 2022-11-09 | $5.94M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $350.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.32M 10-Q · filed 2022-08-09 | $5.43M derived: sum of 3 quarters · filed 2023-03-01 | $5.96M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $973.00K 10-Q · filed 2022-05-10 | $5.08M derived: sum of 2 quarters · filed 2023-03-01 | $5.61M derived: sum of 3 quarters · filed 2023-03-01 | $5.63M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $4.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.64M derived: sum of 2 quarters · filed 2023-03-01 | $4.65M derived: sum of 3 quarters · filed 2023-03-01 | $5.38M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $535.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $548.00K derived: sum of 2 quarters · filed 2021-11-09 | $1.27M 10-Q · filed 2021-11-09 | $1.30M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $740.00K 10-Q · filed 2021-08-09 | $767.71K derived: sum of 3 quarters · filed 2022-03-01 | $755.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $727.00K 10-Q · filed 2021-05-10 | $754.71K derived: sum of 2 quarters · filed 2022-03-01 | $742.00K derived: sum of 3 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $27.71K derived: 10-K 12 month − 6-K 9 month · filed 2022-03-01 | $15.00K derived: sum of 2 quarters · filed 2022-03-01 | $854.00K 10-K · filed 2022-03-01 | ||
| 2019-09-30 | -$12.71K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $826.29K 6-K · filed 2020-01-21 | |||
| 2019-06-30 | $839.00K 6-K · filed 2020-09-11 | ||||
| 2018-12-31 | $575.21K derived: 10-K 12 month − 6-K 9 month · filed 2021-03-01 | $692.00K 10-K · filed 2021-03-01 | $691.53K 20-F · filed 2019-03-29 | ||
| 2018-09-30 | $116.79K 6-K · filed 2020-01-21 | ||||
| 2017-12-31 | $2.73M 20-F · filed 2020-04-29 | $2.73M 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |